SCHEMBL20109213

SCHEMBL20109213

C/C=C(/CC)P1(=S)N(c2ccccc2)CCN1c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.37
CHRNA7 P36544 3/20 0.36
DRD2 P14416 1/20 0.34
SIGMAR1 Q99720 1/20 0.34
PHGDH O43175 1/20 0.33
MGLL Q99685 1/20 0.33
HTT P42858 2/20 0.32
ALDH1A1 P00352 2/20 0.32
MAPK1 P28482 2/20 0.32
POLB P06746 1/20 0.32
TSHR P16473 3/20 0.32
ALOX15 P16050 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
USP2 O75604 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ATM Q13315 1/20 0.32
BLM P54132 1/20 0.32
HSD17B10 Q99714 2/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20109216 1.00 MAPT (0.37) MAPTCHRNA7DRD2SIGMAR1PHGDH
SCHEMBL20109210 0.89 CHRNA7 (0.33) MAPTCHRNA7DRD2SIGMAR1PHGDH
SCHEMBL20109209 0.89 CHRNA7 (0.33) MAPTCHRNA7DRD2SIGMAR1PHGDH
SCHEMBL20109208 0.88 SMN1; SMN2 (0.40) MAPTCHRNA7ALDH1A1MAPK1TSHR
SCHEMBL20109212 0.86 TRPA1 (0.32) MAPTCHRNA7DRD2SIGMAR1ALDH1A1
SCHEMBL20109224 0.86 CHRNA7 (0.32) MAPTCHRNA7DRD2SIGMAR1MAPK1
SCHEMBL20109239 0.83 MAPT (0.37) MAPTCHRNA7DRD2SIGMAR1PHGDH
SCHEMBL20109237 0.83 MAPT (0.37) MAPTCHRNA7DRD2SIGMAR1PHGDH
SCHEMBL20109138 0.82 MAPT (0.36) MAPTCHRNA7DRD2SIGMAR1HTT
SCHEMBL20109139 0.82 MAPT (0.36) MAPTCHRNA7DRD2SIGMAR1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180118770-A1 N-Heterocyclic Phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118770-A1 N-Heterocyclic Phosphines NANP, PPIP5K2, PHPT1 MAPT 4371/4885CHRNA7 3780/4885DRD2 2561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.